Clinical Trial Services / Management
Total Trials
21
As Lead Sponsor
9
As Collaborator
12
Total Enrollment
3,858
NCT00014339
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2000
Completion: Not specified
NCT00426777
Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer
Start: Jan 31, 2007
Completion: Feb 28, 2009
NCT00632905
Bone Health Observational Study
Phase: N/A
Start: Sep 30, 2007
Completion: Mar 31, 2016
NCT00992251
Eligard Observational Registry for Patients With Prostate Cancer
Start: Aug 31, 2009
Completion: Mar 31, 2014
NCT01366053
Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists
Start: Mar 31, 2011
Completion: Jul 31, 2015
NCT01386684
Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study
Role: Collaborator
Start: Jun 28, 2011
Completion: Sep 8, 2016
NCT04057859
PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training
Start: Nov 30, 2013
Completion: Jul 31, 2020
NCT03605459
Trial to Assess the Efficacy of the Comfort Plug™in Preventing Urinary Incontinence (COMFORT STUDY)
Start: Feb 4, 2014
Completion: Apr 3, 2018
NCT04060043
Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer
Phase: Early Phase 1
Start: Feb 21, 2017
Completion: Jan 2, 2018
NCT03348527
A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer
Phase: Phase 2
Start: May 12, 2017
Completion: Nov 30, 2020
NCT04097002
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
Phase: Phase 1/2
Start: Nov 12, 2019
Completion: Dec 31, 2024
NCT04165408
Trial to Assess the Safety and Clinical Performance of Contino® in Preventing Urinary Incontinence
Start: Nov 19, 2019
Completion: Dec 30, 2025
NCT04735705
Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
Start: Apr 1, 2021
Completion: Sep 9, 2021
NCT05652959
Real-world Performance and Safety of Cerviron® in the Treatment of Vaginitis
Start: May 20, 2021
Completion: May 30, 2022
NCT05668806
RWE Study in the Treatment of Cervical Lesions of Various Etiology
Completion: Jul 31, 2021
NCT04735718
Clinical Investigation To Evaluate Cerviron Ovules® in Cervix Lesions Postoperative Care
Start: Aug 1, 2021
Completion: Jan 16, 2023
NCT05135104
Study Of Real-World Evidence In Patients Treated With Palbociclib During a 2.5 Years Follow-Up Period
Start: Dec 15, 2021
Completion: May 25, 2024
NCT05654610
Real-world Evidence Study on the Performance and Safety of Halova Ovules
Start: Mar 1, 2022
Completion: Jul 31, 2022
NCT05396547
Study On The Performance And Safety Of The LEDINBIO CE Device On Visual Acuity In Subjects With Cataract
Start: Jun 28, 2022
Completion: Feb 2, 2025
NCT06473974
Open-label, Single-arm, Proof of Concept Study in Subjects with Mild-to-moderate Facial Hyperpigmentation
Start: Jan 1, 2025
Completion: Dec 15, 2025
NCT06903663
The Epidemiology of Patients Treated With ATZ+BEV in Real Life Setting
Start: Apr 30, 2025
Completion: Dec 31, 2025
Loading map...